Northwest Biotherapeutics reported $16.21M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Agenus USD 153.98M 15.68M Mar/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
Eisai JPY 184.6B 49.83B Jun/2026
Merck USD 51.08B 4.41B Jun/2026
Northwest Biotherapeutics USD 16.21M 15.59M Mar/2026
Pfizer USD 60.5B 70M Jun/2026
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 25.22B 2.21B Jun/2026